[1]
Poltorak, V., Kravchun, N., Gorshunskaya, M. and Krasova, N. 2014. Glimepiride (Amaryl®) in the Treatment of Patients with Diabetes Mellitus Type 2 (Pathophysiological Rationale and Clinical Implementation). INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine). 1.57 (Mar. 2014), 77–89. DOI:https://doi.org/10.22141/2224-0721.1.57.2014.76425.